Transition from Paraneoplastic Pemphigus to Bullous Pemphigoid after a 26-month Remission
DOI:
https://doi.org/10.2340/actadv.v105.43633Keywords:
Autoimmune blistering disease, Bullous pemphigoid, PemphigusDownloads
References
Antiga E, Bech R, Maglie R, Genovese G, Borradori L, Bockle B, et al. S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol 2023; 37: 1118–1134. DOI: https://doi.org/10.1111/jdv.18931
Hiroyasu S, Turner CT, Richardson KC, Granville DJ. Proteases in pemphigoid diseases. Front Immunol 2019; 10: 1454. DOI: https://doi.org/10.3389/fimmu.2019.01454
Tsuchisaka A, Kawano H, Yasukochi A, Teye K, Ishii N, Koga H, et al. Immunological and statistical studies of anti-BP180 antibodies in paraneoplastic pemphigus. J Invest Dermatol 2014; 134; 2283–2287. DOI: https://doi.org/10.1038/jid.2014.151
Bhattacharya D. Instructing durable humoral immunity for COVID-19 and other vaccinable diseases. Immunity 2022; 55: 945–964. DOI: https://doi.org/10.1016/j.immuni.2022.05.004
Maag JLV, Fisher OM, Levert-Mignon A, Kaczorowski DC, Thomas ML, Hussey DJ, et al. Novel aberrations uncovered in Barrett’s esophagus and esophageal adenocarcinoma using whole-transcriptome sequencing. Mol Cancer Res 2017; 15: 1558–1569. DOI: https://doi.org/10.1158/1541-7786.MCR-17-0332
Elenkov IJ. Glucocorticoids and the Th1/Th2 balance. Ann NY Acad Sci 2004; 1024: 138–146. DOI: https://doi.org/10.1196/annals.1321.010
Published
How to Cite
License
Copyright (c) 2025 Daisuke Matsumoto, Mako Mine, Norito Ishii, Daisuke Tsuruta, Sho Hiroyasu

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.